Hepatitis C/ Human Immunodeficiency Virus Coinfection

1 clinical trials · Condition

Record	Firm	Date
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients (NCT02103439)	Biocad	2013-06-06

Every clearance here is in the API, with alerts when new ones post.